MAP2K7 and neoplasm: The demonstration of the activation of the MAPK cascade by RAS, together with previous findings showing that oncogenic RAS mutants trigger increased MAPK phosphorylation and activity independently of receptor activation [133], indicated that mutant RAS-mediated, constitutive activation of the RAF/MEK/ERK kinase cascade leads to uncontrolled cell proliferation and eventual tumor development.